Key result
Cardiac 123I-MIBG imaging demonstrates potential clinical utility beyond heart failure for evaluating autonomic dysfunction in conditions such as myocardial infarction, atrial fibrillation, amyloidosis, and diabetes mellitus.
Why the study?
What are the potential clinical indications for cardiac 123I-MIBG imaging beyond heart failure?
What are the potential clinical indications for cardiac 123I-MIBG imaging beyond heart failure?
Cardiac 123I-MIBG imaging has potential clinical indications beyond heart failure, including risk assessment in myocardial infarction, atrial fibrillation, amyloidosis, and cardiotoxicity, though further standardization and guideline implementation are needed.
123Iodine-meta-iodobenzylguanidine (123I-MIBG) imaging can visualize cardiac sympathetic innervation by providing (semi-) quantitative information on the myocardial sympathetic activity.
No takes yet. Share an insight, caveat, or question.
Dimitriu‐Leen et al. (2016) conducted a review in Cardiac diseases beyond heart failure. 123I-MIBG imaging was evaluated. Cardiac 123I-MIBG imaging demonstrates potential clinical utility beyond heart failure for evaluating autonomic dysfunction in conditions such as myocardial infarction, atrial fibrillation, amyloidosis, and diabetes mellitus.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: